Cargando…

A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures

BACKGROUND: Romosozumab is a bone-forming antibody that increases bone formation and decreases bone resorption. We conducted a double-blinded, randomized, phase-2, dose-finding trial to evaluate the effect of romosozumab on the clinical outcomes of open reduction and internal fixation of intertrocha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schemitsch, Emil H., Miclau, Theodore, Karachalios, Theofilos, Nowak, Lauren L., Sancheti, Parag, Poolman, Rudolf W., Caminis, John, Daizadeh, Nadia, Dent-Acosta, Ricardo E., Egbuna, Ogo, Chines, Arkadi, Maddox, Judy, Grauer, Andreas, Bhandari, Mohit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Bone and Joint Surgery, Inc. 2020
Materias:	Scientific Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508283/ https://www.ncbi.nlm.nih.gov/pubmed/31977817 http://dx.doi.org/10.2106/JBJS.19.00790

Ejemplares similares

Skeletal responses to romosozumab after 12 months of denosumab
por: McClung, Michael R., et al.
Publicado: (2021)

Influence of Renal Function on Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Romosozumab
por: Hsu, Cheng‐Pang, et al.
Publicado: (2022)

The Effect of Irrigation Fluid on Periprosthetic Joint Infection in Total Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis
por: Wood, Thomas, et al.
Publicado: (2020)

Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild‐to‐Moderate Chronic Kidney Disease
por: Miller, Paul D, et al.
Publicado: (2022)

Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension
por: Miyauchi, Akimitsu, et al.
Publicado: (2019)

Romosozumab for osteoporosis
Publicado: (2021)

Antibiotic utilization in open fractures
por: Atwan, Yousif, et al.
Publicado: (2020)

Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab
por: Kendler, D.L., et al.
Publicado: (2019)

Romosozumab for the treatment of osteoporosis
por: McClung, Michael R.
Publicado: (2018)

A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab
por: McClung, M. R., et al.
Publicado: (2020)

Outcome measurements in orthopedic
por: Bhandari, Mohit, et al.
Publicado: (2007)

Romosozumab and cardiovascular safety in Japan
por: Takeuchi, Yasuhiro
Publicado: (2021)

Is the use of bipolar hemiarthroplasty over monopolar hemiarthroplasty justified? A propensity score-weighted analysis of a multicentre randomized controlled trial
por: Comeau-Gauthier, Marianne, et al.
Publicado: (2023)

Romosozumab Enhances Vertebral Bone Structure in Women With Low Bone Density
por: Poole, Kenneth ES, et al.
Publicado: (2021)

Multicenter collaborative for orthopaedic research in India: An opportunity for global leadership
por: Mathew, George, et al.
Publicado: (2008)

The 3-min appraisal of a meta-analysis
por: Hussain, Nasir, et al.
Publicado: (2011)

Romosozumab in osteoporosis: yesterday, today and tomorrow
por: Wu, Dong, et al.
Publicado: (2023)

Closed Limb Fractures With Compromised Vascularization: A Narrative Review
por: Vannabouathong, Christopher, et al.
Publicado: (2019)

Who, if anyone, may benefit from a total hip arthroplasty after a displaced femoral neck fracture?: a post hoc subgroup analysis of the HEALTH trial
por: Frihagen, Frede, et al.
Publicado: (2022)

Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study
por: Baek, Ki-Hyun, et al.
Publicado: (2021)

Open fractures: Current treatment perspective
por: Minehara, Hiroaki, et al.
Publicado: (2023)

Profile of romosozumab and its potential in the management of osteoporosis
por: Lim, Sian Yik, et al.
Publicado: (2017)

Denosumab versus romosozumab for postmenopausal osteoporosis treatment
por: Kobayakawa, Tomonori, et al.
Publicado: (2021)

Romosozumab and antiresorptive treatment: the importance of treatment sequence
por: Cosman, Felicia, et al.
Publicado: (2022)

Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active‐Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial
por: Brown, Jacques P., et al.
Publicado: (2021)

Impact of romosozumab on serum calcium concentration and factors predicting the fluctuations in calcium concentration upon romosozumab administration: A multicenter retrospective study
por: Inose, Hiroyuki, et al.
Publicado: (2022)

Romosozumab-aqqg in the Treatment of Osteoporosis in a Patient With Hypophosphatasia
por: Khanjee, Naveed, et al.
Publicado: (2022)

Romosozumab or alendronate for fracture prevention in East Asian patients: a subanalysis of the phase III, randomized ARCH study
por: Lau, E. M. C., et al.
Publicado: (2020)

India-Based Knee Osteoarthritis Evaluation (iKare): A Multi-Centre Cross-Sectional Study on the Management of Knee Pain and Early Osteoarthritis in India
por: Sancheti, Parag, et al.
Publicado: (2017)

Intramedullary Nailing vs Sliding Hip Screw in Trochanteric Fracture Management: The INSITE Randomized Clinical Trial
por: Schemitsch, Emil H., et al.
Publicado: (2023)

The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study
por: Geusens, Piet, et al.
Publicado: (2019)

Individualized surgery in primary total knee arthroplasty
por: Karachalios, Theofilos, et al.
Publicado: (2020)

Management strategies for prosthetic joint infection: long-term infection control rates, overall survival rates, functional and quality of life outcomes
por: Karachalios, Theofilos, et al.
Publicado: (2021)

Romosozumab, clinical trials, and real-world care of patients with osteoporosis
por: Lewiecki, E. Michael
Publicado: (2020)

Romosozumab: a novel bone anabolic treatment option for osteoporosis?
por: Kerschan-Schindl, Katharina
Publicado: (2019)

Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
por: Lim, Sian Yik
Publicado: (2022)

Romosozumab efficacy and safety in European patients enrolled in the FRAME trial
por: Langdahl, Bente, et al.
Publicado: (2022)

Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
por: Trepanowski, Nicole, et al.
Publicado: (2023)

Total hip arthroplasty: Survival and modes of failure
por: Karachalios, Theofilos, et al.
Publicado: (2018)

An Unusual Central Dislocation of a Total Hip Arthroplasty Due to Severe Wear of a Ceramic on Cross-linked Polyethylene Bearing Coupling - A Case Report
por: Athanaselis, Efstratios, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_99fmgetkltupv631t0nq0vcpgd